X0306 4 2019-04-08 0 0001328143 Adamas Pharmaceuticals Inc ADMS 0001568249 Rhodes Jennifer J C/O ADAMAS PHARMACEUTICALS, INC. 1900 POWELL ST., SUITE 1000 EMERYVILLE CA 94608 0 1 0 0 CBO, GC & Compliance Officer Common Stock 2019-04-08 4 A 0 30000 0.00 A 61612 D Stock Option (Right to Buy) 6.81 2019-04-08 4 A 0 60000 0.00 A 2029-04-07 Common Stock 60000 60000 D The shares of Common Stock are to be acquired upon the vesting of certain Restricted Stock Units granted to the Reporting Person. The Restricted Stock Units shall vest as follows: 25% of the total number of Restricted Stock Units will vest on each of March 20, 2020, March 20, 2021, March 20, 2022 and March 20, 2023, subject to Reporting Person's Continuous Service as of each such date. The Option shares shall vest as follows: 1/48th of the option shares shall vest on the 1st of each month beginning with May 1, 2019, subject to Reporting Person's Continuous Service as of each such date. /s/Jennifer Rhodes 2019-04-10